In this webinar, Juliet Moritz and Benjamen Varsano share their expertise on one of the most critical decisions in rare disease research—choosing the right Contract Research Organization (CRO).
Rare disease trials come with unique challenges—complex regulatory pathways, small patient populations, and high unmet medical needs—making CRO selection a pivotal factor for success. Juliet and Benjamen highlight the essential criteria biopharma and biotech companies should consider, including:
– A CRO’s track record and expertise in rare disease research
– In-depth knowledge of regulatory requirements across global health authorities
– Effective patient engagement and recruitment strategies
– Transparent and clear communication during the proposal and bid defense process
Whether starting a new rare disease program or reassessing potential CRO partners, this webinar provides practical insights and guidance to help ensure clinical trials are strategically positioned for success.